Publish Time: 2025-07-08 Origin: Bioteke
As of mid-2025, dengue fever is surging worldwide, with alarming increases reported in Southeast Asia, Latin America, and parts of Africa. According to the World Health Organization (WHO), over 6 million cases have been reported globally in the first half of the year, many of which resulted in hospitalization and severe complications. Rapid identification and timely intervention are critical in controlling outbreaks and reducing mortality.
In this context, accurate and rapid diagnostic solutions are essential. The Bioteke Dengue NS1/IgG/IgM Rapid Test Kit provides an efficient, cost-effective solution for early detection and differentiation of dengue infections at the point of care.
Bioteke Dengue NS1/IgG/IgM rapid test is an immunochromatographic assay designed for the qaulitative detection of Dengue NS1 antigen, IgM, and IgG against all types of dengue viruses using human serum, plasma, or whole blood.
▋Key Features
Triple detection: Identifies NS1 antigen and IgG/IgM antibodies
Fast results in 15–20 minutes
No equipment required: Ideal for rapid diagnostic testing
CE marked, manufactured under ISO 13485-certified processes
Shelf life: 24 months, stored at 2–30°C
Available in 20 tests per box, OEM/customization available
Why Bioteke?
Bioteke has over 20 years of experience in in vitro diagnostic (IVD) innovation and is recognized for:
1. Reliable and certified production
2. Comprehensive portfolio of rapid diagnostic kits (infectious diseases, respiratory diseases, tumor markers, sexually transmitted diseases, women's health)
3. Flexible partnerships with global distributors, importers and NGOs
4. Quick-response technical and logistical support
Join the fight against dengue.
Partner with Bioteke to bring accurate, rapid and affordable dengue diagnostics to your region.
Contact us today to request samples, get pricing or distribution rights.